Two Health Incubator Helsinki teams, CurifyLabs and Solid-IO, are fast-tracking their way into the U.S. market with the support of Business Finland and Mayo Clinic’s AMPlify program.

The U.S. represents 40% of the global healthcare market, providing vast opportunities for Finnish health tech startups. With the growing demand for innovative digital solutions, American healthcare systems are now shifting their innovation centers towards international co-development platforms.

One example of these platforms is AMPlify, a market entry program organized by Business Finland in cooperation with Mayo Clinic, one of the top-ranked hospitals in the U.S. The program aims to offer guidance on all critical aspects of commercial and clinical success to significantly shorten the time to market.

We are happy to announce that two Health Incubator Helsinki teams, CurifyLabs and Solid-IO, are among the 12 Finnish health tech teams accepted for the program in fall 2024.

CurifyLabs, which joined Health Incubator Helsinki in 2021, has brought to market a unique 3D printing technology for fast and accurate compounding of personalized medicines in pharmacies.

Solid-IO aims to revolutionize cancer care by eliminating guesswork and enhancing accessibility to immunotherapy with a drug testing platform based on tumor-on-a-chip technology. Solid-IO was selected for the Health Incubator Helsinki program in 2024.

“We are proud to see that two of our teams are now paving their way into the U.S. market with the AMPlify program. This selection highlights these teams’ high potential and qualifications for new programs. The U.S. market is central to most innovative solutions and is by far the biggest globally – all support that can be provided to these teams is essential for a successful market entry,” says Christian Lardot, Health Incubator Helsinki Lead.